Status:
UNKNOWN
Cross-condition Validation of the Steroid PRO
Lead Sponsor:
University of the West of England
Collaborating Sponsors:
Johns Hopkins University
University of Pittsburgh
Conditions:
Inflammatory Disease
Immune System Disorder
Eligibility:
All Genders
18+ years
Brief Summary
Testing a questionnaire about treatment with steroids for skin, lung or gastric conditions
Detailed Description
Glucocorticoid drugs, also known as 'steroids', are used to treat a range of diseases. It is well-known that steroids can cause many unwanted side-effects. The investigators are interested in measurin...
Eligibility Criteria
Inclusion Criteria:
- Aged ≥ 18 years old
- Diagnosed with an autoimmune or inflammatory respiratory, gastroenterology or dermatology condition
- Treatment with glucocorticoids with intravenous or oral glucocorticoids for an autoimmune or inflammatory condition within the previous year (or longer duration).
- Ability to give consent.
Exclusion Criteria:
- Aged <18 years old
- No autoimmune or inflammatory respiratory, gastroenterology or dermatology diagnosis
- Not treated with glucocorticoids with intravenous or oral glucocorticoids for an autoimmune or inflammatory condition within the previous year (or longer duration)
- Unable to give consent
Key Trial Info
Start Date :
June 1 2022
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
May 31 2024
Estimated Enrollment :
60 Patients enrolled
Trial Details
Trial ID
NCT06314451
Start Date
June 1 2022
End Date
May 31 2024
Last Update
March 20 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of the West of England
Bristol, United Kingdom, BS2 8HW